Last updated at 23 Jun 2024 04:35 AM
Director
DIN: 09006385
Sharan Uday Asher is currently associated with 2 companies in various capacities such as Whole-time director and Director. They serve as a Director at ERAGON VENTURES LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09006385.Sharan Uday Asher has previously been associated with 2 companies in roles such as Director and Additional Director.Sharan Uday Asher is currently involved in 2 different roles. Their most recent position is with SYNIT DRUGS PVT LTD as a Director. The first company Sharan Uday Asher was appointed to as a director was ERAGON VENTURES LIMITED. Sharan Uday Asher is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Sharan Uday Asher is currently associated with 2 companies in various capacities such as Whole-time director and Director. They serve as a Director at ERAGON VENTURES LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09006385.Sharan Uday Asher has previously been associated with 2 companies in roles such as Director and Additional Director.Sharan Uday Asher is currently involved in 2 different roles. Their most recent position is with SYNIT DRUGS PVT LTD as a Director. The first company Sharan Uday Asher was appointed to as a director was ERAGON VENTURES LIMITED. Sharan Uday Asher is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (2)
1 Year 6 Months Interval
Company Name | Designation | Date of Appointment |
---|---|---|
ERAGON VENTURES LIMITED | Whole-time director | 01-Jan-2022 |
SYNIT DRUGS PVT LTD | Director | 30-Sep-2022 |